Durbin inquires about the transparency of Commission meetings.
03/20/2012
https://www.congress.gov...
we believe the ad risks misleading patients by omitting any safety or side effect information
For over 10 years, I have dedicated a large part of my public service to that 'damn fish'.
I have received highly credible information from multiple sources that Kash Patel has been personally directing the ongo...
And the differences are not as significant when it comes to the investigative resources and mission of the SEC as oppose...